A multicenter pilot study of a bronchial valve for the treatment of severe emphysema.

Journal Article (Clinical Trial;Journal Article;Multicenter Study)

BACKGROUND: Chronic obstructive pulmonary disease (COPD) affects millions of people and has limited treatment options. Surgical treatments for severe COPD with emphysema are effective for highly selected patients. A minimally invasive method for treating emphysema could decrease morbidity and increase acceptance by patients. OBJECTIVE: To study the safety and effectiveness of the IBV(R) Valve for the treatment of severe emphysema. METHODS: A multicenter study treated 91 patients with severe obstruction, hyperinflation and upper lobe (UL)-predominant emphysema with 609 bronchial valves placed bilaterally into ULs. RESULTS: Valves were placed in desired airways with 99.7% technical success and no migration or erosion. There were no procedure-related deaths and 30-day morbidity and mortality were 5.5 and 1.1%, respectively. Pneumothorax was the most frequent serious device-related complication and primarily occurred when all segments of a lobe, especially the left UL, were occluded. Highly significant health-related quality of life (HRQL) improvement (-8.2 +/- 16.2, mean +/- SD change at 6 months) was observed. HRQL improvement was associated with a decreased volume (mean -294 +/- 427 ml, p = 0.007) in the treated lobes without visible atelectasis. FEV(1), exercise tests, and total lung volume were not changed but there was a proportional shift, a redirection of inspired volume to the untreated lobes. Combined with perfusion scan changes, this suggests that there is improved ventilation and perfusion matching in non-UL lung parenchyma. CONCLUSION: Bronchial valve treatment of emphysema has multiple mechanisms of action and acceptable safety, and significantly improves quality of life for the majority of patients.

Full Text

Duke Authors

Cited Authors

  • Sterman, DH; Mehta, AC; Wood, DE; Mathur, PN; McKenna, RJ; Ost, DE; Truwit, JD; Diaz, P; Wahidi, MM; Cerfolio, R; Maxfield, R; Musani, AI; Gildea, T; Sheski, F; Machuzak, M; Haas, AR; Gonzalez, HX; Springmeyer, SC; IBV Valve US Pilot Trial Research Team,

Published Date

  • 2010

Published In

Volume / Issue

  • 79 / 3

Start / End Page

  • 222 - 233

PubMed ID

  • 19923790

Pubmed Central ID

  • PMC7068788

Electronic International Standard Serial Number (EISSN)

  • 1423-0356

Digital Object Identifier (DOI)

  • 10.1159/000259318


  • eng

Conference Location

  • Switzerland